THC Global Group Limited (ASX:THC) agreed to acquire Tetra Pty Ltd from Meta Growth Corp. (TSXV:META) and others for AUD3 million on May 12, 2020. As a part of transaction, Meta Growth Corp. will sell 30% stake in Tetra Pty Ltd. Out of total consideration, AUD2.5 million will be paid in THC Shares and AUD0.5 million in cash. As a part of consideration, in first stage, which is at completion, THC Global Group Limited will issue 4.5 million THC Shares at AUD0.25 per share, 5 million Unlisted Options exercisable at AUD0.40 expiring two years after issue and AUD0.25 million in cash, in second stage, which is three months after completion, THC Global Group Limited will issue AUD0.75 million in THC Shares, with the issue price calculated as the lower of 105% of the 10 trading day VWAP prior to issue date or AUD0.35 and AUD0.125 million in cash and in third stage, which is six months after completion, THC Global Group Limited will issue AUD0.625 million in THC Shares, with the issue price calculated as the lower of 105% of the 10 trading day VWAP prior to issue date or AUD0.40 and AUD0.125 million in cash. If stage 2 THC Shares are issued at AUD0.35 and stage 3 THC Shares are issued at AUD0.40, the total number of shares being issued by THC Global will be 8.205357 million. The cash consideration will be funded from the existing cash of THC Global Group Limited. THC Global will maintain Tetra's autonomy and does not anticipate any changes to the current operations, product offering, or fundamental business ethos of Tetra. Post acquisition, Andrew McLachlan, Stephen Clarke, Mona Singh, Samuel Bannister and Kellie Charles, members of Medical Advisory Board have confirmed they will remain on the board. Transaction is expected to be completed on or around May 25, 2020.

THC Global Group Limited (ASX:THC) completed the acquisition of Tetra Pty Ltd from Meta Growth Corp. (TSXV:META) and others on May 28, 2020.